2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Febrile Neutropenia
7
Neoplasms
5
Hematologic Neoplasms
3
Neutropenia
2
Fever
2
Urinary Bladder Neoplasms
1
Sepsis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Other Infectious Diseases
1
Leukemia, Myeloid, Acute
1
Emergencies
1
Interventions
Anti-Bacterial Agents
2
ziprasidone
1
telavancin
1
soybean oil, phospholipid emulsion
1
drotrecogin alfa activated
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
Simvastatin
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Povidone-Iodine
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Multiplex Polymerase Chain Reaction
1
Molindone
1
Methylprednisolone
1
Methods
1
Meropenem
1
Massage
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sepsis
×
Meropenem
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled